ADGM is the ticker symbol for Adagio Medical Holdings, Inc., a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks ADGM with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is ADGM a good stock to buy?

ADGM is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our 32-signal AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/ADGM.

Where does 13F Pro source ADGM data?

All Adagio Medical Holdings, Inc. fundamentals and ownership data come directly from SEC EDGAR. Adagio Medical Holdings, Inc. files with the SEC under CIK 2006986. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

Adagio Medical Holdings, Inc.(ADGM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Adagio Medical Holdings, Inc. (ADGM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ADGM is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.3m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Adagio Medical Holdings, Inc. reports net income of $-6.7M, free cash flow of $-5.3M. Top institutional holders of ADGM by reported 13-F value include PERCEPTIVE ADVISORS, ADAGE CAPITAL PARTNERS GP, L.L.C., ADAR1 Capital Management, based on the most recent SEC filings. ADGM trades on the Nasdaq exchange and files with the SEC under CIK 2006986. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ADGM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Adagio Medical Holdings, Inc. directly from SEC EDGAR.

Revenue

$0.00

Net Income

$-6.7M

Free Cash Flow

$-5.3M

ADGM key financials by period

Adagio Medical Holdings, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2023	10-K	$300.0K	$-36.6M	—

Institutions holding ADGM

Institutional investors reporting a position in Adagio Medical Holdings, Inc. on SEC Form 13F.
Institution	Shares	Value	Reported
PERCEPTIVE ADVISORS	9,876,586	$6.4M	2026-06-30
ADAGE CAPITAL PARTNERS GP, L.L.C.	1,258,501	$820.0K	2026-06-30
ADAR1 Capital Management	1,205,447	$785.5K	2026-06-30
Alyeska Investment Group, L.P.	1,159,615	$755.6K	2026-06-30
Sio Capital Management	698,989	$455.5K	2026-06-30
SILVERARC CAPITAL MANAGEMENT	224,360	$146.2K	2026-06-30
Shaolin Capital Management	171,170	$111.5K	2026-06-30
VANGUARD CAPITAL MANAGEMENT	108,954	$71.0K	2026-06-30
Affinity Asset Advisors	80,000	$52.1K	2026-06-30
GEODE CAPITAL MANAGEMENT	79,115	$51.5K	2026-06-30

SEC EDGAR: CIK 2006986 →

Adagio Medical Holdings, Inc.

ADGM

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.3M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.